SEC Comment Letter for MARRONE BIO INNOVATIONS INC (CIK 0001441693) — Mar 26, 2020
MARRONE BIO INNOVATIONS INC (CIK 0001441693)
Date: March 26, 2020 · CIK: 0001441693 · Accession: 0000000000-20-002649
AI Filing Summary & Sentiment
File numbers found in text: 333-237331
Letter
March 26, 2020 Pamela G. Marrone, Ph.D. Chief Executive Officer Marrone Bio Innovations Inc. 1540 Drew Avenue Davis, CA 95618 Re:Marrone Bio Innovations Inc. Registration Statement on Form S-1 Filed March 20, 2020 File No. 333-237331 Dear Dr. Marrone: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Paul Fischer at 202-551-3415 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alfredo Silva, Esq.
Show Raw Text
March 26, 2020
Pamela G. Marrone, Ph.D.
Chief Executive Officer
Marrone Bio Innovations Inc.
1540 Drew Avenue
Davis, CA 95618
Re:Marrone Bio Innovations Inc.
Registration Statement on Form S-1
Filed March 20, 2020
File No. 333-237331
Dear Dr. Marrone:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Paul Fischer at 202-551-3415 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Alfredo Silva, Esq.